跳至主要内容
临床试验/ACTRN12613001053718
ACTRN12613001053718招募中2 期

Effect of Turmeric, Kalongi and its combination in improving the parameters of Metabolic syndrome in adults -a randomized controlled trial. – TAK-MS Trial

Aga Khan University Medical College,0 个研究点目标入组 248 人开始时间: 2013年9月20日最近更新:
适应症

试验速览

阶段
2 期
状态
招募中
发起方
入组人数
248

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 65 Years(—)
性别
Male

入选标准

  • Obese males residing and permanent residents of Hijrat colony with a waist circumference of or >90 cm with any 2 more features of Metabolic syndrome (MS) who are not on any regular medications for Diabetes (pre-Diabetic), Dyslipidemia, blood pressure (pre hypertensive) or obesity and do not require any medications as per ATP III guidelines and American Diabetic Association guidelines for control of Diabetes or Hypertension.

排除标准

  • *Patients with known Diabetes, Hypertension or Coronary Heart disease or who require immediate pharmacological treatment.
  • *Patients with wheat allergy.
  • *Patients already taking Herbal supplements.
  • *Patients on medications for Hyperlipidemia or Obesity.
  • *Debilitated patients or patients on regular medications for chronic diseases like steroids, immunosuppressants and Warfarin will also be excluded.

研究者

发起方
Aga Khan University Medical College,

相似试验